AHRQ: Toolkit for Improving Skin Care and MDRO Prevention in Long-Term Care Settings

SHEA: Multisociety Guidance for Infection Prevention and Control in Nursing Homes (10/20/2025)

  • The guidance offers recommendations for infection prevention and control (IPC) in nursing homes to address challenges including medical acuity and the rise of multidrug-resistant organisms.
  • It emphasizes the importance of IPC leadership, training, and adherence to precautions while also considering the balance between maintaining a home-like environment and ensuring effective infection prevention measures.

SHEA/APIC: Multisociety Guidance for Infection Prevention and Control in Nursing Homes (10/28/2025)

  • This guidance document updates the 2008 SHEA/Association for Professionals in Infection Control and Epidemiology (APIC) guideline: Infection Prevention and Control in the Long-Term Care Facility and is intended to assist nursing homes in the United States in defining and implementing their infection prevention and control (IPC) programs and practices.
  • Recommendations and implementation suggestions address IPC leadership, staffing, and resources, healthcare personnel and residents‘ adherence to precautions and effective hand hygiene, outbreak preparedness, training, occupational health, cleaning and disinfection in the care environment, and the involvement of IPC in the facility.

CMS: Proposed Rules for Prospective Payment Systems and Quality Reporting Programs (4/30/2025)

CDC: 2023 National and State Healthcare-Associated Infections (HAI) Progress Report (11/2024)

The 2023 National and State Healthcare-Associated Infections (HAI) Progress Report provides a summary of national and state level data for select HAIs across four healthcare settings: acute care hospitals (ACHs), critical access hospitals (CAHs), inpatient rehabilitation facilities (IRFs) and long-term acute care hospitals (LTACHs).
In acute care hospitals, standardized infection ratios (SIRs) showed statistically significant improvement in 2023 compared to 2022 for all HAIs except surgical site infections.

Pneumococcal Vaccine Recommendations

The recommended age for receiving the pneumococcal vaccination was lowered from 65 to 50 years to give more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infection substantially increases.